Soru

Zorluk: OrtaHematology and Oncology

A 52-year-old man is hospitalized to undergo induction chemotherapy for newly diagnosed Burkitt lymphoma. Twenty-four hours after the initiation of the cytotoxic regimen, he reports new-onset muscle cramps, palpitations, and nausea. His temperature is 37.2°C (99.0°F), pulse is 108/min, and blood pressure is 110/70 mm Hg. Physical examination reveals normal heart sounds and clear lungs.

Laboratory studies show the following:
TestResultReference Range
Potassium6.8 mEq/L3.5-5.0 mEq/L
Creatinine2.8 mg/dL0.7-1.3 mg/dL
Calcium6.8 mg/dL8.4-10.2 mg/dL
Phosphorus8.5 mg/dL2.5-4.5 mg/dL
Uric acid14.2 mg/dL3.5-7.2 mg/dL

An electrocardiogram (ECG) reveals peaked T waves and a shortened QT interval. The patient is currently receiving aggressive intravenous normal saline and allopurinol. Which of the following is the most appropriate next step in management?

  1. A
    Intravenous rasburicase
  2. B
    Urgent hemodialysis
  3. C
    Oral sevelamer
  4. Intravenous calcium gluconateCevap
  5. E
    Intravenous insulin and glucose

Cevap

Intravenous calcium gluconate
This patient is experiencing tumor lysis syndrome (TLS), an oncologic emergency caused by the massive release of intracellular contents following cytotoxic therapy for rapidly proliferating tumors, such as Burkitt lymphoma. This massive cell death results in hyperkalemia, hyperphosphatemia, hypocalcemia, and hyperuricemia. The most immediate and critical life-threatening complication of TLS is severe hyperkalemia, which can trigger fatal cardiac arrhythmias (e.g., ventricular fibrillation). This patient has a critically elevated potassium level of 6.8 mEq/L and peaked T waves on his ECG, indicating active myocardial toxicity. The absolute most appropriate initial step in management is the administration of intravenous calcium gluconate (or calcium chloride). Calcium directly antagonizes the depolarization effects of hyperkalemia by raising the threshold potential, thereby stabilizing the cardiac myocyte membrane. It works within minutes, buying crucial time to implement additional therapies that actually remove potassium from the body.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation and laboratory results.
The patient has developed tumor lysis syndrome (TLS), characterized by severe hyperkalemia, hyperuricemia, hyperphosphatemia, hypocalcemia, and acute kidney injury following chemotherapy.
To identify the primary pathophysiologic process occurring after cytotoxic therapy.
2
Evaluate the ECG findings in the context of the severe electrolyte abnormalities.
Peaked T waves indicate active cardiac toxicity resulting from the severe hyperkalemia (6.8 mEq/L).
To determine the most immediate life-threatening complication.
3
Determine the most appropriate immediate medical intervention.
Administration of intravenous calcium gluconate is required immediately.
Calcium antagonizes the membrane actions of hyperkalemia, providing immediate cardioprotection while other therapies are prepared to lower the total serum potassium.

Anahtar Kavram

In patients with tumor lysis syndrome presenting with severe hyperkalemia and ECG changes, the immediate administration of intravenous calcium gluconate is the most critical next step to stabilize the cardiac membrane and prevent fatal arrhythmias.
Bu soruyu puanla